Drug intelligence / Profile preview

Shu Gan Ning Shen dripping pills

Development stage: Unknown
Lead developer: Beijing Kaijin Technology
Administration: Oral

Overview

Shu Gan Ning Shen dripping pills is a Traditional Chinese Medicine (TCM) formulation developed by Beijing Kaijin Technology Co., Ltd. for the treatment of insomnia disorder, specifically targeting the liver qi stagnation pattern. In TCM theory, this pattern involves the disruption of qi flow, leading to emotional instability and sleep disturbances. The medication is designed to soothe the liver and calm the spirit (Shen). It has been evaluated in a randomized, double-blind, placebo-controlled Phase 3 clinical trial in China to assess its efficacy and safety in adult patients.

Other names: Shugan Ningshen Diwan

Beyond the preview

Go deeper on Shu Gan Ning Shen dripping pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shu Gan Ning Shen dripping pills.

Explore the full profile